Juvéderm Ultra 3 is a hyaluronic acid dermal filler used in some international markets for selected facial wrinkles, folds, and lip treatment planning. It is part of the Juvéderm Ultra family and is commonly discussed for medium-depth correction rather than very superficial fine lines or deep structural contouring.
For clinics considering Juvéderm Ultra 3, accurate product positioning and regulatory verification are essential. Juvéderm Ultra 3 is not approved for use in every jurisdiction, including the United States, and clinics should confirm local approval status, labeling, import rules, and professional-use requirements before purchase or treatment.
This guide reviews Juvéderm Ultra 3’s clinical positioning, patient-selection considerations, safety profile, sourcing requirements, and responsible use for qualified clinics and licensed medical practitioners.
Access professional dermal filler options available from Health Supplies Plus.
Key Takeaways
- Market-specific product: Juvéderm Ultra 3 is available in some international markets, but it is not approved for use in every country. Clinics must verify local regulatory status before purchase or treatment.
- HA-based filler: Juvéderm Ultra 3 is a hyaluronic acid filler commonly discussed for medium-depth facial wrinkles and selected lip treatment planning where approved.
- Not a universal filler: It should not be positioned for all treatment areas, deep structural contouring, under-eye hollows, or very superficial fine lines.
- Lidocaine consideration: Juvéderm Ultra 3 with lidocaine may improve comfort during treatment, but discomfort, swelling, bruising, and tenderness can still occur.
- Safety protocols matter: Clinics using HA fillers should have hyaluronidase available and written protocols for recognizing and managing suspected vascular compromise.
- Authentic sourcing matters: Clinics should purchase only from reliable professional suppliers and verify packaging, lot number, expiration date, storage, labeling, and regulatory status.
What Is Juvéderm Ultra 3?
Juvéderm Ultra 3 is an injectable hyaluronic acid filler in the Juvéderm Ultra family. Hyaluronic acid, often abbreviated as HA, is a naturally occurring substance found in the body that helps support hydration and tissue volume.
Juvéderm Ultra 3 is commonly positioned in some markets for medium-depth lines, facial folds, and selected lip augmentation or contouring where approved. Exact indications, product name, packaging, and approved uses vary by country.
Clinics should avoid assuming that Juvéderm Ultra 3 has the same regulatory status or indications as Juvéderm Ultra XC, Juvéderm Ultra Plus XC, or other Juvéderm products. Product names can be similar, but approvals and labeling may differ.
Regulatory Status and Product Verification
Before buying or using Juvéderm Ultra 3, clinics should verify whether the product is approved or authorized in their jurisdiction. This is especially important because some Juvéderm Ultra products are approved in one market but not another.
Clinics should confirm:
- Whether Juvéderm Ultra 3 is authorized for professional use in their country
- Whether import or distribution restrictions apply
- The exact product name and formulation
- Whether the product contains lidocaine
- Current product labeling and instructions for use
- Professional eligibility and scope-of-practice rules
- Storage, handling, and documentation requirements
Juvéderm Ultra 3 should not be described as FDA-approved for use in the United States. Clinics serving U.S. patients should rely only on products approved for their market.
How Juvéderm Ultra 3 Fits Into the Juvéderm Portfolio
The Juvéderm collection includes multiple HA fillers designed for different treatment roles. Some products are intended for lips, others for folds, cheeks, chin, temples, under-eye hollows, jawline, or skin-quality treatment planning depending on product and jurisdiction.
Juvéderm Ultra 3 may be considered in markets where approved when the treatment goal involves moderate correction and product characteristics match the patient’s anatomy and treatment area.
It should not be treated as interchangeable with:
- Juvéderm Voluma: Commonly associated with deeper structural support in selected areas where approved.
- Juvéderm Volbella: Commonly associated with more refined lip, perioral, and delicate-area treatment planning where approved.
- Juvéderm Volux: Specifically positioned for jawline definition in markets where approved.
- Juvéderm Ultra XC: A different product name and regulatory pathway in the U.S. market.
Potential Treatment-Planning Uses
Where approved and appropriate, Juvéderm Ultra 3 may be discussed for selected treatment goals such as:
- Moderate facial wrinkles and folds
- Nasolabial fold treatment planning
- Marionette line treatment planning
- Selected lip volume or contouring goals
- Perioral support in appropriate patients
Juvéderm Ultra 3 should not be positioned as the primary choice for under-eye hollows, nose reshaping, deep jawline contouring, major chin projection, or superficial etched lines unless supported by local labeling, advanced training, and patient-specific assessment.
Patient Selection for Juvéderm Ultra 3
Good outcomes depend on appropriate patient selection. A consultation should determine whether the patient’s concern is suitable for HA filler and whether Juvéderm Ultra 3 is the appropriate product.
Assessment should include:
- Patient goals and desired level of correction
- Medical history and allergy review
- Medication and supplement review
- Previous filler, surgery, laser, or complication history
- Skin quality, tissue thickness, and facial anatomy
- Baseline asymmetry
- Whether another product or treatment category is more appropriate
- Discussion of risks, limitations, and alternatives
Patients should have realistic expectations. Juvéderm Ultra 3 may support selected correction goals, but it cannot stop aging, replace surgery, treat significant skin laxity, or guarantee symmetry.
Treatment Planning and Professional Use
Juvéderm Ultra 3 should only be administered by qualified, trained medical professionals in accordance with local laws, product labeling, scope-of-practice rules, and professional standards.
A responsible treatment workflow may include:
- Confirming product authenticity and regulatory status
- Reviewing current product labeling before use
- Performing a full medical and aesthetic assessment
- Obtaining informed consent
- Documenting treatment area and baseline anatomy
- Using sterile technique
- Providing written aftercare and follow-up guidance
Detailed injection depth, device selection, product amount, and placement technique should follow current product instructions, formal training, and practitioner judgment. General marketing content should not be used as a substitute for hands-on instruction or clinical protocols.
Safety Profile and Side Effects
Juvéderm Ultra 3 is an injectable HA filler and can cause side effects or complications. Safe use requires anatomical knowledge, proper product selection, sterile technique, informed consent, conservative planning, and complication-management protocols.
Common Temporary Side Effects
Common temporary effects may include:
- Swelling
- Bruising
- Redness
- Tenderness
- Pain or discomfort at injection sites
- Itching
- Firmness, bumps, or temporary lumps
- Temporary asymmetry or contour irregularity
Less Common but Serious Risks
Less common complications may include infection, delayed inflammatory reaction, nodules, filler migration, poor aesthetic outcome, or vascular complications.
Patients should contact the clinic urgently if they experience severe pain, skin blanching, unusual discoloration, visual symptoms, worsening swelling, fever, drainage, or signs of infection.
Because Juvéderm Ultra 3 is an HA filler, it may be dissolved with hyaluronidase when clinically appropriate. Clinics using HA fillers should have hyaluronidase available and written protocols for recognizing and managing suspected vascular compromise.
Contraindications and Precautions
Contraindications and precautions should be verified against the current product label in the clinic’s jurisdiction. General HA filler and Juvéderm-family considerations may include:
- Severe allergies, history of anaphylaxis, or multiple severe allergies
- Known hypersensitivity to hyaluronic acid products
- Allergy to lidocaine if the product contains lidocaine
- History of allergy to Gram-positive bacterial proteins where applicable
- Active infection or inflammation at or near the treatment site
- Pregnancy or breastfeeding considerations
- Unrealistic expectations
- Complex prior filler complications or migration
- Medical conditions that increase treatment risk
Patients should not stop prescribed anticoagulants, antiplatelet medicines, or other medications unless advised by the appropriate healthcare provider.
Aftercare for Juvéderm Ultra 3
Aftercare instructions should be provided in writing and tailored to the patient and treatment area. Depending on clinic protocol, patients may be advised to:
- Avoid strenuous exercise for a short period
- Avoid excessive heat, saunas, steam rooms, hot yoga, or tanning for a short period
- Avoid unnecessary pressure, rubbing, or massage unless instructed
- Avoid alcohol for a short period if recommended
- Use cold compresses gently if advised
- Monitor for unusual pain, color change, or swelling
- Contact the clinic promptly with concerning symptoms
Patients should not massage or manipulate treated areas unless specifically instructed by the treating practitioner.
Authentic Sourcing and Clinic Procurement
Authentic sourcing is essential for patient safety and consistent treatment planning. Counterfeit, expired, improperly stored, diverted, or unauthorized dermal fillers can create serious medical, legal, and reputational risks.
When purchasing Juvéderm Ultra 3 or other Juvéderm products, clinics should verify:
- Supplier reputation and professional eligibility requirements
- Product authenticity
- Exact product name and formulation
- Jurisdiction-specific approval status
- Packaging integrity
- Lot number and expiration date
- Storage and handling requirements
- Product labeling and documentation
- Whether import, prescription, or professional-use restrictions apply
Health Supplies Plus supports qualified clinics and licensed medical practitioners with professional aesthetic supply options. Clinics should always confirm that the selected product is permitted for use in their market before purchase or treatment.
Buying Juvéderm Ultra 3 From Health Supplies Plus
Health Supplies Plus provides access to professional dermal filler products for qualified clinics and licensed medical practitioners. When stocking Juvéderm Ultra 3, clinics should plan inventory based on local regulations, product availability, treatment volume, storage requirements, expiration dates, and patient demand.
Reliable sourcing supports product authenticity, lot tracking, storage integrity, patient safety, and consistent clinical outcomes.
Juvéderm Ultra 3 Frequently Asked Questions
Conclusion
Juvéderm Ultra 3 is an HA dermal filler used in some international markets for selected facial wrinkles, folds, and lip treatment planning. It may be a useful product for clinics operating in jurisdictions where it is authorized, but it should not be positioned as FDA-approved in the United States or as interchangeable with other Juvéderm products.
For clinics, responsible use depends on regulatory verification, accurate product positioning, qualified administration, patient selection, authentic sourcing, conservative planning, and clear aftercare. Juvéderm Ultra 3 should not be presented as a universal filler, a guaranteed lip solution, or an appropriate option for every facial area.
Shop Juvéderm Ultra 3 at Health Supplies Plus.
This content is intended for professional informational purposes only and does not replace medical advice, diagnosis, treatment, emergency protocols, product-specific training, manufacturer instructions, legal guidance, regulatory guidance, or applicable clinical protocols. Juvéderm Ultra 3 and other dermal filler treatments should only be performed by qualified medical professionals in accordance with local laws, product labeling, scope-of-practice rules, and appropriate standards of care.
About the Author: Doris Dickson is a specialist writer for Health Supplies Plus, focusing on the aesthetic medicine industry. She diligently researches cosmetic treatments and products to provide clear, concise information relevant to licensed medical professionals. Her work supports Health Supplies Plus’s commitment to being a reliable informational resource and trusted supplier for the aesthetic community.
Disclaimer: The content provided in this article is intended for informational purposes only and is directed towards licensed medical professionals. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment, nor does it constitute an endorsement of any specific product or technique. Practitioners must rely on their own professional judgment, clinical experience, and knowledge of patient needs, and should always consult the full product prescribing information and relevant clinical guidelines before use. Health Supplies Plus does not provide medical advice.